Cargando…

Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals?

Background: Despite the global efforts to antagonize carbapenem-resistant Acinetobacter baumannii (CRAB) spreading, it remains an emerging threat with a related mortality exceeding 40% among critically ill patients. The purpose of this review is to provide evidence concerning the best infection prev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medioli, Filippo, Bacca, Erica, Faltoni, Matteo, Burastero, Giulia Jole, Volpi, Sara, Menozzi, Marianna, Orlando, Gabriella, Bedini, Andrea, Franceschini, Erica, Mussini, Cristina, Meschiari, Marianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405503/ https://www.ncbi.nlm.nih.gov/pubmed/36009885 http://dx.doi.org/10.3390/antibiotics11081015

Ejemplares similares

Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study
por: Meschiari, Marianna, et al.
Publicado: (2021)

Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature
por: Burastero, Giulia Jole, et al.
Publicado: (2022)

Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature
por: Bacca, Erica, et al.
Publicado: (2021)

A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit
por: Meschiari, Marianna, et al.
Publicado: (2021)

1979. Five-Year Impact of an Antimicrobial Stewardship Program on Nosocomial Candidemia: An Interrupted Time-Series Analysis Study
por: Bedini, Andrea, et al.
Publicado: (2019)

Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review
por: Dolci, Giovanni, et al.
Publicado: (2023)

Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature
por: Meschiari, Marianna, et al.
Publicado: (2020)

Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period
por: Franceschini, E., et al.
Publicado: (2020)

Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015–2021)
por: Meschiari, Marianna, et al.
Publicado: (2022)

Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections
por: Gallerani, Altea, et al.
Publicado: (2023)

The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study
por: Milic, Jovana, et al.
Publicado: (2021)

636. Genome Epidemiology of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in the United States
por: Iovleva, Alina, et al.
Publicado: (2019)

337 Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii (CRAb) among ICU Patients Detected by CRAb-LAMP
por: Yamamoto, Norihisa, et al.
Publicado: (2014)

First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
por: Meschiari, Marianna, et al.
Publicado: (2022)

Bibliometric Examination of Global Scientific Research about Carbapenem-Resistant Acinetobacter Baumannii (CRAB)
por: Jangid, Himanshu, et al.
Publicado: (2023)

The Impact of COVID-19 on UNAIDS 90–90–90 Targets: Calls for New HIV Care Models
por: Guaraldi, Giovanni, et al.
Publicado: (2021)

A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients
por: Alteri, Claudia, et al.
Publicado: (2022)

2443. Impact of Antimicrobial Stewardship on the Incidence of Carbapenem-Resistant Pseudomonas aeruginosa: A Nonlinear Time-Series Analysis Approach to Identify Carpapenem Thresholds
por: Meschiari, Marianna, et al.
Publicado: (2019)

Outbreak of carbapenem-resistent Acinetobacter baumannii (CRAB) in a surgical department of a university hospital
por: Messler, S, et al.
Publicado: (2011)

Detecting carbapenem-resistant Acinetobacter baumannii (CRAB) carriage: Which body site should be cultured?
por: Nutman, Amir, et al.
Publicado: (2020)

Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections
por: Watkins, Richard R, et al.
Publicado: (2023)

Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections
por: Meschiari, Marianna, et al.
Publicado: (2021)

Hypokalemia in Patients with COVID-19
por: Alfano, Gaetano, et al.
Publicado: (2021)

Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia—Challenges, strengths, and opportunities in a global health emergency
por: Ferrari, Davide, et al.
Publicado: (2020)

Risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization
por: Cogliati Dezza, Francesco, et al.
Publicado: (2023)

Antimicrobial Peptide Cec4 Eradicates the Bacteria of Clinical Carbapenem-Resistant Acinetobacter baumannii Biofilm
por: Liu, Weiwei, et al.
Publicado: (2020)

Rifampicin Enhanced Carbapenem Activity with Improved Antibacterial Effects and Eradicates Established Acinetobacter baumannii Biofilms
por: Nwabor, Lois Chinwe, et al.
Publicado: (2023)

Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
por: Mussini, Cristina, et al.
Publicado: (2021)

Endemicity and diversification of carbapenem-resistant Acinetobacter baumannii in an intensive care unit
por: Doughty, Emma L., et al.
Publicado: (2023)

Diversity of carbapenem-resistant Acinetobacter baumannii and bacteriophage-mediated spread of the Oxa23 carbapenemase
por: Abouelfetouh, Alaa, et al.
Publicado: (2022)

Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria
por: Santoro, Antonella, et al.
Publicado: (2020)

A New Twist: The Combination of Sulbactam/Avibactam Enhances Sulbactam Activity against Carbapenem-Resistant Acinetobacter baumannii (CRAB) Isolates
por: Pasteran, Fernando, et al.
Publicado: (2021)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
por: DelleFave, Amber, et al.
Publicado: (2023)

Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients
por: Alfano, Gaetano, et al.
Publicado: (2021)

Carbapenem-resistant Acinetobacter baumannii from Brazil: role of carO alleles expression and bla(OXA-23) gene
por: Fonseca, Erica Lourenço, et al.
Publicado: (2013)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Induced Heteroresistance in Carbapenem-Resistant Acinetobacter baumannii (CRAB) via Exposure to Human Pleural Fluid (HPF) and Its Impact on Cefiderocol Susceptibility
por: Mezcord, Vyanka, et al.
Publicado: (2023)

2134. Impact of ADC ß-lactamase amino acid variation on cefiderocol (FDC) susceptibility in carbapenem-resistant Acinetobacter baumannii (CRAb) strains
por: Iovleva, Alina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fi8leuekbbeuhfjb3t7mbftj0v